The Roles of MRI, DYNEELAX and Stress X-ray in First-Line Diagnosis of Cruciate Ligament Injury
Launched by KAOHSIUNG VETERANS GENERAL HOSPITAL. · Feb 7, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at new ways to diagnose injuries to the knee's cruciate ligaments, which are important for stability. Traditionally, doctors assess these injuries by physically examining the knee, but this method can be unreliable. The trial is testing two new tools: an MRI scan and a special device called DYNEELAX that measures knee movement more accurately. The goal is to see how well these new methods can detect differences in knee movement between injured and healthy knees.
To participate in this trial, individuals need to have a confirmed or suspected injury to their anterior cruciate ligament (ACL) or posterior cruciate ligament (PCL). If a person is unable to have an MRI or has had previous knee surgeries or fractures on the injured knee, they won't be eligible to join. Participants will undergo tests using the MRI and the DYNEELAX device, which will help doctors better understand their knee injuries. This study is currently recruiting patients and aims to improve diagnosis and treatment for knee ligament injuries in the future.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Patients are diagnoed as ACL/PCL injury or suspect ligament sprain at Kaohsiung veteran general hospital.
- • Exclusion Criteria: Unable receing MRI exam, any op history of knee or fracture history on the impaired knee.
About Kaohsiung Veterans General Hospital.
Kaohsiung Veterans General Hospital is a leading medical institution in Taiwan, renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital combines cutting-edge medical technology with a team of experienced researchers and healthcare professionals dedicated to improving treatment outcomes and enhancing the quality of life for veterans and the broader community. With a focus on a wide range of therapeutic areas, Kaohsiung Veterans General Hospital actively contributes to the global medical research landscape, fostering collaboration and knowledge exchange to drive significant advancements in clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Kaohsiung, 高雄市, Taiwan
Patients applied
Trial Officials
Yi Ping Wei, Dr.
Principal Investigator
Kaohsiung veteran general hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported